In recent years licensing deals have dominated the pharmaceutical industry.

Taking into account the growth in research and drug development in 2016 and notably in 2015, licensing deals will continue to shape the deal making landscape.

Click to enlarge

Source: GlobalData

 

More licensing deals mean these companies are positioning themselves for growth, by diversifying in order to increase their market share.

In both the first quarters of 2016 and 2017, the number of licensing deals within the oncology space dominated.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

This is in line with 2016 predictions of a surge in cancer research and development in 2017.